Last reviewed · How we verify
UTAA09 cells for infusion — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
UTAA09 cells for infusion (UTAA09 cells for infusion) — PersonGen BioTherapeutics (Suzhou) Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| UTAA09 cells for infusion TARGET | UTAA09 cells for infusion | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- UTAA09 cells for infusion CI watch — RSS
- UTAA09 cells for infusion CI watch — Atom
- UTAA09 cells for infusion CI watch — JSON
- UTAA09 cells for infusion alone — RSS
Cite this brief
Drug Landscape (2026). UTAA09 cells for infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/utaa09-cells-for-infusion. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing